For the year ending 2025-12-31, GRTX has $7,196K in assets. $645K in debts. $6,375K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 6,375 | |||
| Subscription receivable | 0 | |||
| Prepaid expenses and other current assets | 720 | |||
| Total current assets | 7,095 | |||
| Other assets | 101 | |||
| Total assets | 7,196 | |||
| Accounts payable | 265 | |||
| Accrued expenses | 380 | |||
| Total current liabilities | 645 | |||
| Royalty purchase liability | 0 | |||
| Warrant liability | 0 | |||
| Total liabilities | 645 | |||
| Series b redeemable convertible preferred stock, 0.001 par value 10,000,000 shares authorized 119,318 shares issued and outstanding at december 31, 2025 and 2024 | 2,577 | |||
| Common stock, 0.001 par value 200,000,000 shares authorized 75,462,390 shares issued and outstanding at december 31, 2025 and 2024 | 75 | |||
| Additional paid-in capital | 311,213 | |||
| Accumulated deficit | -307,314 | |||
| Total stockholders' deficit | 3,974 | |||
| Total liabilities, redeemable convertible preferred stock and stockholders' deficit | 7,196 | |||
Galera Therapeutics, Inc. (GRTX)
Galera Therapeutics, Inc. (GRTX)